multiple-sclerosis

Knowledge-graph topic · documents ABOUT multiple-sclerosis across the archive

729Documents about multiple-sclerosis

Documents about multiple-sclerosis

Impact of cancer on multiple sclerosis–related healthcare and disease-modifying drug use: A multinational cohort study#337511HAL (France)
Essential Trace Element Levels in Multiple Sclerosis: Bridging Demographic and Clinical Gaps, Assessing the Need for Supplementation#652904IBISS
Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis#829903ClinicalTrials.gov
Onset of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients#832586ClinicalTrials.gov
Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis#862133ClinicalTrials.gov
Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis#863630ClinicalTrials.gov
The Effect of High Tone Power Therapy on Fatigue and Functional Outcomes in Multiple Sclerosis#863796ClinicalTrials.gov
Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis#866134ClinicalTrials.gov
Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis#868205ClinicalTrials.gov
Effects of Ten-Weeks Power Training on Neuromuscular Performance, Heart Rate Variability, Sleep Quality and Mobility in Persons With Multiple Sclerosis#870367ClinicalTrials.gov
An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)#873758ClinicalTrials.gov
Investigation of the Effects of Technology Supported Different Physiotherapy Approaches on Patients With Multiple Sclerosis#875163ClinicalTrials.gov
A run-in Study on the Safety and Tolerability of a Fasting Mimicking Diet in Relapsing Remitting Multiple Sclerosis#875845ClinicalTrials.gov
Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis#891552ClinicalTrials.gov
Effectiveness of Home-Based Exercise and Brain Stimulation for Reducing Fatigue in Patients With Multiple Sclerosis#899630ClinicalTrials.gov
Impact of Adding Cognitive Behaviour Therapy to Supervised Pilates-based Core Stability Training in Patients With Multiple Sclerosis#900797ClinicalTrials.gov
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis#911783ClinicalTrials.gov
Investigation of the Effects of Pilates Training Combined with Whole Body Vibration on Balance and Mobility in Individuals with Multiple Sclerosis#913446ClinicalTrials.gov
Time to be Ready to Void: a New Tool to Assess the Time Needed to Perform Micturition in Multiple Sclerosis#915148ClinicalTrials.gov
Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design#917942ClinicalTrials.gov
Smoking accelerates immunosenescence in multiple sclerosis.#367952NCBI PubMed Central
Exercise and Brain Health in MS#810360ClinicalTrials.gov
MS and Health Cohort#966604ClinicalTrials.gov
Rethinking EDSS-based ambulation assessment in multiple sclerosis using continuous variable monitoring#307854Europe PMC
Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)#826085ClinicalTrials.gov
Measuring the Balance Improvement on Multiple Sclerosis Patients After a Short Training Period With an APOS (All Phase Of Step Cycle) Kit#828096ClinicalTrials.gov
Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.#829500ClinicalTrials.gov
A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)#831325ClinicalTrials.gov
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis#837845ClinicalTrials.gov
A Trial to Compare the Effectiveness of Two Rehabilitation Programs for Multiple Sclerosis Patients#843106ClinicalTrials.gov
A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab#850558ClinicalTrials.gov
Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)#873218ClinicalTrials.gov
The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment#913730ClinicalTrials.gov
Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis#915608ClinicalTrials.gov
Analysis of antiphospholipid antibodies and cystatin C in multiple sclerosis patients [Análisis de anticuerpos antifosfolipídicos y cistatina C en pacientes con esclerosis múltiple]#948798Repositorio de Universidad Autónoma de Chile.
External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims database#202514HAL (France)
Understanding the Role of Hypothalamic–Pituitary–Gonadal Axis in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis#482732IBISS
Interaction between smoking and <i>HLA-A*02:01</i> in multiple sclerosis progression#642346Europe PMC
Summary of Research: Cognition and Employment Status of People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-Year CLARIFY-MS Study#642355Europe PMC
Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study#642408Europe PMC
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis#832107ClinicalTrials.gov
Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination#847333ClinicalTrials.gov
Comparison of Gait Metrics in Patients With Stroke, Traumatic Brain Injury, and Multiple Sclerosis#859627ClinicalTrials.gov
To Investigate the Effect of Aerobic Exercise on Neurophysiological Values and Functionality in Individuals With Multiple Sclerosis.#868759ClinicalTrials.gov
An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis#868937ClinicalTrials.gov
Home-Based Exergame Rehabilitation for Upper Limb Function in People With Multiple Sclerosis#870512ClinicalTrials.gov
How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose#872990ClinicalTrials.gov
A Self-management Program to Prevent Falls in People With Multiple Sclerosis#874004ClinicalTrials.gov
Improving Cognitive Recovery in Multiple Sclerosis#877452ClinicalTrials.gov
Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis#879689ClinicalTrials.gov

Topic record · derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.